A mutation in CFTR produces different phenotypes depending on chromosomal background

Sandra Kiesewetter(Johns Hopkins Medicine), Milan Maçek(Johns Hopkins University), Claire Davis(Johns Hopkins University), S M Curristin(Johns Hopkins Medicine), C.S. Chu(National Institutes of Health), Colin A. Graham(Wessex Regional Genetics Laboratory), Antony E. Shrimpton(MRC Institute of Genetics and Molecular Medicine), Siobhan M. Cashman(Trinity College Dublin), L.‐C. Tsui(Hospital for Sick Children), John E. Mickle(Boston University), J. Amos(Boston University), W. Edward Highsmith(University of North Carolina at Chapel Hill), Anthony P. Shuber(Sequenom (United States)), David R. Witt(Kaiser Permanente), Ronald G. Crystal(National Heart Lung and Blood Institute), Garry R. Cutting(Johns Hopkins Medicine)
Nature Genetics
November 1, 1993
10.1038/ng1193-274
Cited by 441

Abstract

Related Papers

The Metabolic Basis of Inherited Disease
|Annals of Internal Medicine|1990|4k
Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene
Julian Zielenski, Richard Rozmahel, Dominique Bozon et al.|Genomics|1991|546
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
Chin-Shyan Chu, Bruce C. Trapnell, S M Curristin et al.|Nature Genetics|1993|518
Genetic determination of exocrine pancreatic function in cystic fibrosis.
Peter Kristidis, Dominique Bozon, Mary Corey et al.|PubMed|1992|446
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.
Batsheva Kerem, Julian Zielenski, D. Markiewicz et al.|Proceedings of the National Academy of Sciences|1990|424